Phase III TAISHAN-302 trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer
Reports and Proceedings
Reports and Proceedings
Latest News Releases
Updates every hour. Last Updated: 1-Nov-2026 07:16 ET (1-Nov-2026 12:16 GMT/UTC)
Reports and Proceedings
Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer
Reports and Proceedings
Sacituzumab govitecan plus pembrolizumab does not meet primary endpoints in first-line PD-L1-high metastatic NSCLC
Reports and Proceedings
Perioperative atezolizumab plus chemotherapy more than doubles event-free survival in resectable stage II–IIIB NSCLC
Reports and Proceedings
Phase 1 study supports recommended phase 3 dose for investigational EGFR x HER3 antibody-drug conjugate in EGFR-mutated lung cancer
Reports and Proceedings
Pumitamig plus elfetabart drozuntecan shows encouraging early activity in small cell lung cancer
Reports and Proceedings
Extended-interval tarlatamab dosing shows consistent activity and safety in previously treated small cell lung cancer
Reports and Proceedings
Local consolidative therapy does not improve survival after dual immunotherapy in metastatic NSCLC
Reports and Proceedings
Subcutaneous tarlatamab shows favorable safety profile and antitumor activity in extensive-stage small cell lung cancer
Reports and Proceedings
New ‘smart’ nanoparticles help the immune system better attack tumours
Peer-Reviewed Publication